Up | AC
Home Page
Food and
Drug Administration
Peripheral and Central Nervous System Drugs Advisory Committee
October 23, 2008
BRIEFING INFORMATION
FDA
Disclaimer
Portions of this document have been determined to be exempt
from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. §
552).
FDA Briefing Material (pdf)
Avid
Radiopharmaceuticals, Inc.
Disclaimer
The statements contained in this document(s) are those of
the company’s, not FDA, and FDA does not necessarily agree with the company's
statements. FDA has not made a final determination about the safety or
effectiveness of the product described in this document.
Briefing Material (pdf)
Bayer
HealthCare Pharmaceuticals, Inc.
Disclaimer
The statements contained in this document(s) are those of
the company’s, not FDA, and FDA does not necessarily agree with the company's
statements. FDA has not made a final determination about the safety or
effectiveness of the product described in this document.
Briefing Material (pdf)
GE
Healthcare, Inc.
Disclaimer
The statements contained in this document(s) are those of
the company’s, not FDA, and FDA does not necessarily agree with the company's
statements. FDA has not made a final determination about the safety or
effectiveness of the product described in this document.
Briefing Material (pdf)